Adherence Intelligence Learn Pilot Run Your Numbers FAQ Book an Opportunity Assessment
Adherence Intelligence for Metabolic Health

The 90-day pilot.

One program, one adherence window, an agreed baseline, and a credible comparison. At the end you make a scale, modify, or stop decision on evidence rather than impression.

WHAT IT PROVES

Five questions the pilot answers.

  • Incremental completion of defined program milestones
  • Appropriate continuation, or a resolved care plan
  • Incremental collected or retained revenue
  • Staff workload and intervention acceptance
  • Safety, escalation, and insufficient-evidence patterns
THE THREE PHASES

Ninety days, in three parts.

DAYS 0 TO 30

Set the baseline

Define the cohort, connect minimum-necessary data, approve intervention rules, and capture your current completion and continuation rates before anything runs.

DAYS 31 TO 60

Run it

Detection operates, barriers are inferred, approved outreach begins, and clinical cases route to your care team.

DAYS 61 TO 90

Measure and decide

Outcomes measured against the agreed comparison, errors and safety reviewed, and a scale, modify, or stop decision made.

THE SPLIT

What each side is responsible for.

Synarmic does

Operating the system

  • Integrates the available signals
  • Configures adherence states and barriers
  • Operates detection continuously
  • Sends approved email and SMS interventions
  • Routes exceptions and clinical cases
  • Tracks responses and outcomes
  • Reports against the agreed comparison

Your clinic does

Authorizing and deciding

  • Signs the BAA and authorizes data access
  • Approves message templates and intervention policies
  • Defines clinical escalation rules
  • Names one operational owner
  • Reviews clinically consequential cases
  • Joins a weekly operating review
WHAT WE NEED

Minimum-necessary data, under a signed BAA.

Detecting that a specific patient is slipping requires associating events with that patient. That is PHI, and it is handled accordingly.

PROGRAM
  • Enrollment and program status
  • Appointment and follow-up history
CLINICAL SIGNALS
  • Lab completion status, not lab values
  • Refill or fulfillment events where available
ATTRIBUTION
  • Existing outreach logs
  • Revenue or renewal outcomes
MEASUREMENT

How we prove it worked.

Patients improve on their own and a good quarter flatters any intervention. We measure so you can tell the difference.

Baseline first

Current completion, continuation, and renewal rates captured before a single intervention is sent.

A credible comparison

A randomized holdout, matched cohort, or phased rollout, agreed before launch so improvement can be distinguished from normal variation.

Reported at the level it earns

Only outcomes observed against the agreed comparison are reported as recovered.

Every number is labeled: MODELEDESTIMATEDMEASURED
THE DECISION

Three honest outcomes at day 90.

SCALE

Extend it

The evidence supports expanding across additional locations or programs.

MODIFY

Adjust it

The cohort, the intervention, or the workflow needs changing before it earns a wider rollout.

STOP

Walk away

There is not sufficient operational or economic evidence. We will say so.

See whether your program is a fit.

A 30-minute working session on your program structure, enrollment volume, and current follow-up model.

Best fit today
  • Multi-location, centralized telehealth, or high-volume single-site
  • Medically supervised weight management as a core program
  • An executive sponsor who can authorize a pilot